Watson Pharmaceuticals, Inc. is a leading specialty pharmaceutical company that develops, manufactures, markets and distributes brand and generic pharmaceutical products. With one of the broadest product offerings in the United States and a track record of service excellence, Watson has earned a solid reputation as a reliable and low-cost provider of quality pharmaceutical products.

We've built a powerful engine - With $2.5 billion in revenue, an impressive global supply chain and a tradition of successfully navigating through a constantly changing environment, Watson continues to invest for the future while opportunistically building on its leading position as a top-tier specialty pharmaceutical company with a valuable portfolio of excellent products.

We have a deep and diverse product portfolio - Watson brings competitive advantages to market that have helped us achieve leadership as the fifth largest pharmaceutical company in the United States today, based on total prescriptions dispensed. Opportunistic, relevant and profitable, we are resolved to conduct our business in a manner that creates lasting value and makes a positive impact on people everywhere.

At the heart of our business is a fervent commitment to service. Driven to make a contribution to people in need, we strive to build lasting relationships and conduct our business with integrity. Today we are working at every level to maintain our tradition of strong customer service and sales support, while seeking ways to create new value for our customers and our company.

Our global R&D organization is dedicated, focused and agile. Leveraging our expertise in drug delivery technology and product development, Watson's steadily expanding internal R&D program fuels future growth by taking promising product candidates through clinical studies. With a robust Brand product pipeline and more than 60 Generics pending approval with the U.S. Food and Drug Administration (FDA), the road ahead looks promising.

This is a time for making bold moves. The execution of Watson's long-term strategic plan and operational activities are solidly underway. We continue to evolve our business and adapt our strategy. Guided by the principles we were founded upon, we will achieve industry leadership by continuing to build a highly competitive global organization, brining a broad portfolio of excellent medicines to market and seeking bold new ways to create value for our shareholders.